Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome

Therapeutic Advances in Endocrinology and Metabolism

Volumn 2, Issue 6, 2011, Pages 235-245

  Pangaribuan, Bertha ^a   Yusuf, Irawan ^b   Mansyur, Muchtaruddin ^b   Wijaya, Andi ^b  

^a Prodia Tower 6th floor Jl Kramat Raya No150   (Indonesia)

^b HASANUDDIN UNIVERSITY   (Indonesia)

Author keywords

adiponectin; insulin resistance; obesity; polycystic ovary syndrome; resistin

Indexed keywords

ADIPONECTIN; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PROLACTIN; RESISTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; LEAN BODY WEIGHT; MENSTRUAL CYCLE; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

EID: 83755179126     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018811423770     Document Type: Article

References (26)

1. Azuma K. Katsukawa F. Oguchi S. Murata M. Yamazaki H. Shimada A. et al. (2003) Correlation between serum resistin level and adiposity in obese individuals. Obesity Res 11: 997–1001.
2. Berg A.H. Combs T.P. Scherer P.E. (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84–89.
3. Bokarewa M. Nagaev I. Dahlbelg L. Smith U. Tarkowski A. (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 5789–5795.
4. Carmina E. Orio F. Palomba S. Cascella T. Longo R.A. Colao A.M. et al. (2005) Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 152: 389–394.
5. Combs T.P. Berg A.H. Rajala M.W. Klebanov S. Iyengar P. Jimenez-Chillaron J.C. et al. (2003) Sexual differentiation, pregnancy, calorie restriction and aging affect the adipocyte-specific protein adiponectin. Diabetes 52: 268–276.
6. Cottam D.R. Schaefer P.A. Shaftan G.W. Velcu L. Angus L.D. (2002) Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 12: 335–342.
7. Das U.N. (2001) Is obesity an inflammatory condition?. Nutrition 7: 953–966.
8. Franks S. McCarthy M.I. Hardy K. (2006) Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 29: 278–285.
9. Holcomb I.N. Kabakoff R.C. Chan T.W. Baker A. Gurney W. Henzel C. et al. (2000) FIZZI, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gen family. EMBO (Eur Mol Biol Organ) J 19: 4046.
10. Hotta K. Funahashi T. Arita Y. Takahashi M. Matsuda M. Okamoto Y. et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595–1599.
11. Kadowaki T. Yamauchi T. (2005) Adiponectin and adiponectin receptors. Endocrine Rev 26: 439–451.
12. Leo V.D. La Marca A. Petraglia F. (2003) Insulin-lowering agents in the management of polycystic ovary syndrome. Endocrine Rev 24: 633–667.
13. Lindsay R.S. Funahashi T. Hanson R.L. Matsuzawa Y. Tanaka S. Tataranni P.A. et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57–58.
14. Pangaribuan B. Yusuf I. Wijaya A. Lawrence G.S. (2006) Biomarkers of adiponectin and resistin in patients with polycystic ovary syndrome (PCOS). Oral presentation at the 11th ASEAN Conference in Medical Laboratory Technology, Jakarta, Indonesia.
15. Panidis D. Koliakos G. Kourtis A. Farmakiotis D. Mouslech T. Rousso D. (2004) Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril 81: 361–366.
16. Panidis D. Kourtis A. Farmakiotis D. Mouslech T. Rousso D. Koliakos G. (2003) Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod 18: 1790–1796.
17. Seow K.M. Juan C.H. Wu L.Y. Hsu Y.P. Yang W.M. Tsai Y.L. et al. (2004) Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod 19: 48–53.
18. Sepilian V. Nagamani M. (2005) Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig 12: 129–134.
19. Steppan C.M. Bailey S.T. Bhat S. Brown E.J. Banerjee R.R. Wright C.M. et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307–312.
20. The Asia–Pacific Perspective. (2002) Redefining obesity and its treatment, WHO Western Pacific Region. International Association for the Study of Obesity.
21. The Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19: 41–47.
22. Tschritter O. Fritsche A. Thamer C. Haap M. Shirkavand F. Rahe S. et al. (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52: 239–243.
23. Vendrell J. Broch M. Vilarrasa N. Molina A. Gómez J.M. Gutiérrez C. et al. (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obesity Res 12: 962–971.
24. Weyer C. Funahashi T. Tanaka S. Hotta K. Matzuzawa Y. Pratley R.E. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930–1935.
25. Xita N. Georgiou I. Chatzikyriakidou A. Vounatsou M. Papassotiriou G.P. Papassotiriou I. et al. (2005) Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51: 416–423.
26. Xita N. Tsatsoulis A. (2006) Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical and genetic association studies. J Clin Endocrinol Metab 91: 1660–1666.